The B.C. Tech Association is calling for the provincial government to provide more technology investment as natural resources become less important to the province’s economy.
Topic: BioTech
Canada needs massive investment into the youth innovation space to support economic diversification
Canada needs “massive” investment in education, transformative learning and innovation programs for young people to support the country’s economic diversification, Cassy Weber, CEO of MindFuel, says in an opinion piece.
The Short Report – July 2, 2020: Saskatchewan moves on blue hydrogen, North sells south, and more
Saskatchewan approved a first-of-its-kind hydrogen production project; the Black Innovation Fellowship (BIF) at Ryerson’s DMZ announced a $1 million program expansion; Kitchener wearable tech company North will be sold to Google’s parent company Alphabet; and more.
adMare BioInnovations launches back-to-back biotech companies
Formed in 2019 from a union of the Centre for Drug Research and Development (CDRD) and the NEOMED Institute, adMare Bioinnovations has already launched 10 companies to date.
Innovation Conversations: Q&A with Molly Shoichet
In an interview with RE$EARCH MONEY, Molly Shoichet discusses her new biotech startup, her experience as Ontario’s chief scientist, and her views on innovation in Canada.
Brain Canada & CQDM fund AbCellera’s cell screening platform technology
AbCellera Biologics Inc and the Univ of British Columbia (UBC) received non-dilutive funding of $1 million from pharma-based consortium CQDM and charitable organization Brain Canada Foundation to advance a discovery platform for next-generation antibody therapeutics. With the additional contribution of $450,000 from AbCellera, the program will leverage AbCellera’s high throughput, single-cell screening platform to allow rapid…
CCRM and the Univ of Queensland partner to commercialize neutropenia treatment
The Univ of Toronto-hosted Centre for the Commercialization of Regenerative Medicine (CCRM) has struck a licensing deal with the UniQuest, the commercialization arm of Brisbane AU-based Univ of Queensland (UQ) to commercialize a treatment for chemotherapy-induced neutropenia. The treatment, developed by researchers at UQ’s Australian Institute for Bioengineering and Nanotechnology, provides a therapeutic dose of…
Microbion Corp received US$25 million in venture funding
Vancouver and Bozeman MT-based -based Microbion Corp has received US$25-million in venture capital to further develop its lead compound for the treatment of antibiotic-resistant infections. The funding is being provided by the Global Health Sciences Venture Fund, a US$500-million joint venture between Vancouver’s Quark Venture Inc and GF Securities, a Hong Kong-based investment bank. The…